Premium
MDD treatment found effective for patients with insomnia
Author(s) -
Canady Valerie A.
Publication year - 2018
Publication title -
mental health weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7583
pISSN - 1058-1103
DOI - 10.1002/mhw.31639
Subject(s) - insomnia , major depressive disorder , antidepressant , food and drug administration , medicine , psychiatry , clinical pharmacology , drug , sleep quality , psychology , pharmacology , anxiety , cognition
An estimated 70 to 90 percent of patients with major depressive disorder (MDD) suffer from insomnia, say researchers in Rome, Italy, who tested the sleep quality of some patients with an antidepressant recently approved by the Food and Drug Administration for MDD treatment. Their findings are published in the British Journal of Clinical Pharmacology .